BlackRock, Inc. 13D and 13G filings for Spectrum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | Spectrum Pharmaceuticals, Inc. SPPI |
BlackRock Inc. BLK |
7,878,203 4.400% |
-7,976,525 (-50.31%) |
Filing |
| 2022-03-09 5:18 pm Sale |
2022-02-28 | 13G | Spectrum Pharmaceuticals, Inc. SPPI |
BlackRock Inc. BLK |
15,854,728 9.700% |
-14,361,219 (-47.53%) |
Filing |
| 2022-01-27 11:00 am Unchanged |
2021-12-31 | 13G | Spectrum Pharmaceuticals, Inc. SPPI |
BlackRock Inc. BLK |
30,215,947 18.400% |
0 (Unchanged) |
Filing |
| 2022-01-25 3:03 pm Purchase |
2021-12-31 | 13G | Spectrum Pharmaceuticals, Inc. SPPI |
BlackRock Inc. BLK |
30,215,947 18.400% |
2,394,968 (+8.61%) |
Filing |
| 2021-01-25 4:49 pm Purchase |
2020-12-31 | 13G | Spectrum Pharmaceuticals, Inc. SPPI |
BlackRock Inc. BLK |
27,820,979 19.100% |
8,986,386 (+47.71%) |
Filing |